Bhangdia, K., Natarajan, A., Rudolfson, N., Verguet, S., Castro, M. C., Dusengimana, J.-M. V., Shyirambere, C., Schleimer, L. E., Shulman, L. N., Umwizerwa, A., Kigonya, C., Butonzi, J., MacDuffie, E., Fadelu, T., O’Neil, D. S., Nguyen, C., Mpunga, T., Keating, N. L., & Pace, L. E. (2025). The association of travel distance and other patient characteristics with breast cancer stage at diagnosis and treatment completion at a rural Rwandan cancer facility. BMC Cancer, 25(1). https://doi.org/10.1186/s12885-025-13489-2

Vaynrub, A., Salazar, B., Feng, Y. E., West, H., Michel, A., Umakanth, S., Crew, K. D., & Kukafka, R. (2025). The breast cancer genetic testing experience: probing the potential utility of an online decision aid in risk perception and decision making. BMC Cancer, 25(1). https://doi.org/10.1186/s12885-024-13408-x

Manne, S., Devine, K., Hudson, S., Kashy, D., O’Malley, D., Paddock, L. E., Bandera, E. V., Llanos, A. A. M., Fong, A., Singh, N., Frederick, S., & Evens, A. M. (2023). Factors associated with health-related quality of life in a cohort of cancer survivors in New Jersey. BMC Cancer, 23(1). https://doi.org/10.1186/s12885-023-11098-5

Vettese, E., Sherani, F., King, A. A., Yu, L., Aftandilian, C., Baggott, C., Agarwal, V., Nagasubramanian, R., Kelly, K. M., Freyer, D. R., Orgel, E., Bradfield, S. M., Kyono, W., Roth, M., Klesges, L. M., Beauchemin, M., Grimes, A., Tomlinson, G., Dupuis, L. L., & Sung, L. (2023). Symptom management care pathway adaptation process and specific adaptation decisions. BMC Cancer, 23(1). https://doi.org/10.1186/s12885-023-10835-0

Yoon, C., Lu, J., Jun, Y., Suh, Y.-S., Kim, B.-J., Till, J. E., Kim, J. H., Keshavjee, S. H., Ryeom, S., & Yoon, S. S. (2023). RETRACTED ARTICLE: KRAS activation in gastric cancer stem-like cells promotes tumor angiogenesis and metastasis. BMC Cancer, 23(1). https://doi.org/10.1186/s12885-023-11170-0

Gallitto, M., Savacool, M., Lee, A., Wang, T. J. C., & Sisti, M. B. (2022). Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-10162-w

Sun, J., Fang, F., Olén, O., Song, M., Halfvarson, J., Roelstraete, B., Khalili, H., & Ludvigsson, J. F. (2022). Normal gastrointestinal mucosa at biopsy and subsequent cancer risk: nationwide population-based, sibling-controlled cohort study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09992-5

Ro, V., Jones, T., Silverman, T., McGuinness, J. E., Guzman, A., Amenta, J., Kukafka, R., & Crew, K. D. (2022). Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study. BMC Cancer, 22(1). https://doi.org/10.1186/s12885-022-09900-x

Oiwa, K., Hosono, N., Nishi, R., Scotto, L., O’Connor, O. A., & Yamauchi, T. (2021). Characterization of newly established Pralatrexate-resistant cell lines and the mechanisms of resistance. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08607-9

Rustgi, S. D., Oh, A., Yang, J. Y., Kang, D., Wolin, E., Kong, C. Y., Hur, C., & Kim, M. K. (2021). Initiation of Somatostatin analogues for neuroendocrine tumor patients: a cost-effectiveness analysis. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08306-5

Brock, K., Homer, V., Soul, G., Potter, C., Chiuzan, C., & Lee, S. (2021). Is more better? An analysis of toxicity and response outcomes from dose-finding clinical trials in cancer. BMC Cancer, 21(1). https://doi.org/10.1186/s12885-021-08440-0